Ownership history in Parallel Advisors, LLC · 18 quarters on record
This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 250 | — | 0% | 0.00% | $33 | — |
| 2025 Q2 | UNCHANGED | 250 | — | 0% | 0.00% | $60 | — |
| 2025 Q1 | UNCHANGED | 250 | — | 0% | 0.00% | $49 | — |
| 2024 Q4 | REDUCED | 250 | -6,933 | -96.5% | 0.00% | $135 | — |
| 2024 Q3 | ADDED | 7,183 | +6,933 | +2773.2% | 0.00% | $7K | — |
| 2024 Q2 | REDUCED | 250 | -1,603 | -86.5% | 0.00% | $244 | — |
| 2022 Q1 | ADDED | 1,853 | +1,041 | +128.2% | 0.00% | $4K | — |
| 2021 Q4 | ADDED | 812 | +97 | +13.6% | 0.00% | $3K | — |
| 2021 Q3 | UNCHANGED | 715 | — | 0% | 0.00% | $3K | — |
| 2021 Q2 | UNCHANGED | 715 | — | 0% | 0.00% | $3K | — |
As of 2025 Q4 — sorted by position size